Skip to main content

Connect and stay on top of the MedTech regulatory landscape globally.

Pure Global is a trusted global leader and growth partner in the healthcare technology industry. Find regulatory insights from our expert team, AI-powered regulatory news tools, and ways to meet us at upcoming events.

Join Our Community

What you get from signing up

Subscribe to our MedTech newsletter for regulatory insights, early resource access, and practical updates that help you stay ahead.

Regulatory Updates

Be informed on regulatory changes

Stay ahead of the curve with timely updates on the latest regulatory changes impacting the MedTech industry.

Upcoming Events

Find us at future MedTech events

Explore our participation in key conferences, summits, and networking opportunities through our upcoming events list.

Blog

Get insights from industry experts

Gain valuable perspectives from experienced MedTech professionals through our blog articles.

News

Regulatory News

Explore regulatory updates and industry insights designed to help you take your product global.

ANVISA clarifies recognized-standard evidence, voluntary use, and manufacturer responsibility. Its current linked list covers orthopedic implant materials.

Australia’s F2026L01167 adds clause 2.2A for specified non-invasive, saline-only flush and patency devices from 8 September 2026. Kinds included because of earlier applications have a five-year transition. From 1 November 2026, the CDSS exemption has five statutory limbs. Compare the amended wording, application dates and unchanged exemption conditions.

NMPA Announcement No. 107 of 2025 replaces the 2014 medical device GMP on 1 November 2026. The revised text has 15 chapters and 132 articles, including three added chapters and separate production and market release responsibilities. The text does not specify any additional grace period after that date. Hubei and Hunan have preparation schedules.

Hong Kong revised GN-01, GN-04, GN-07, GN-08 and GN-09 and five Codes of Practice, effective 1 September 2026. The package addresses certificate verification, conditional approvals and local-manufacturer inspections. GN-08 states five-year listing validity, but COP-03 contains conflicting renewal wording that manufacturers should clarify with MDD.

News

Company News

Browse company milestones, strategic updates, and announcements from Pure Global.

Pure Global has launched a flat-fee pricing model for medical device registration that simplifies global expansion across 13 key markets. With AI-assisted dossier preparation and in-country representation included, manufacturers can easily plan their market access budgets.

Company News

Pure Global has launched AI Builder, a proprietary automation platform that cuts medical device dossier preparation time by up to 75%. The launch introduces a new flat annual pricing model and marks a major step toward on-demand, AI-powered global medical device registration.

Pure Global's new CTO, Ran Chen, brings over a decade of experience in building and scaling machine learning products.

Pure Global is proud to announce its inclusion in the China Business Service Providers (BSP) directory on the International Trade Administration website.

Blog

Recent Blog Posts

Read articles, success stories, and regulatory insights from our global market access experts.

One Device, Three UDI Databases (2026): Build the US, EU and China Work Order

Shared identifiers need separate regulatory mappings. Use corrected database evidence, product-specific calendars and a scoped cost breakdown to plan the work.

Medical Device Technical File Compilation Cost (2026): Build, Buy, or Hybrid?

Technical-file quotes are incomparable until scope, writing, gap closure, reviewer responses, lifecycle maintenance, and authority fees are separated. This report combines public price lines, FDA workload data, EU survey evidence, and a break-even model to show when to build internally, buy a project, or use a hybrid team.

Medical Device Registration Verification 2026: What 15 National Public Data Files Actually Contain

A public register is not a market map. This workpaper names what one row means, which identity fields are filled, and where verification still needs in-country evidence.

Coronary Stent Global Market Access 2026: Class III Almost Everywhere

Coronary stents sit at the highest regulatory tier across major markets. This report maps four US regulatory objects, the PMA supplement lifecycle, eight market-access files, public register evidence, postmarket limits, government fees and a sequencing plan for manufacturers.

Events

Events

Meet the Pure Global team at upcoming events and discuss your regulatory and market access questions.

Medical Fair Asia 2026 event logo
Trade Fair
Marina Bay Sands, Singapore
Sep 9, 2026

Medical Fair Asia

Medical Fair Asia 2026 is a leading healthcare trade exhibition in Singapore, connecting medical specialists, business executives, and industry professionals across hospital, diagnostic, pharmaceutical, medical equipment, and healthcare supply sectors.

Trade Fair
Düsseldorf, Germany
Nov 16, 2026

MEDICA Trade Fair

One of the largest medical B2B trade fairs globally, showcasing products and services across medical imaging, diagnostics, health IT, and more.

essential industry news delivered to your inbox

Thank you for subscribing!
Oops! Something went wrong while submitting the form.
By subscribing, you agree to our Terms of Use.

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Contact us